The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.25
Bid: 7.00
Ask: 7.50
Change: 0.50 (7.41%)
Spread: 0.50 (7.143%)
Open: 6.75
High: 7.25
Low: 6.75
Prev. Close: 6.75
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of options

27 Mar 2023 07:00

RNS Number : 2333U
Braveheart Investment Group plc
27 March 2023
 

27 March 2023

Braveheart Investment Group plc

("Braveheart" or the "Company")

 

Grant of options

 

Braveheart Investment Group (AIM: BRH), announces that, on 24 March 2023, the Company granted options over a total of 2,950,000 ordinary shares of 2p each in the Company ("Ordinary Shares") to the Directors and a service provider to the Company (the "Options"). The Options have been granted pursuant to the Company's share option plan adopted on 16 December 2020. 

 

In order to be eligible to receive new EMI options, Vivian Hallam, Executive Director, has, on 24 March 2023, surrendered 523,808 EMI options previously granted to him on 14 October 2021 and that had an exercise price of 31.5p.

 

In aggregate, 2,900,000 Options have been granted to Directors of the Company, as follows:

 

Name

No. options over Ordinary Shares previously held

No. Options granted

No. options over Ordinary Shares surrendered

Resultant holding of options over Ordinary Shares held

Percentage of the current issued share capital of the Company

Trevor Brown

1,500,000

1,250,000

-

2,750,000

4.3

Vivian Hallam

2,500,000

1,250,000

523,808

3,226,192

5.1

Susan Hagan

50,000

200,000

-

250,000

0.4

Qu Li

0

200,000

-

200,000

0.3

 

The Options granted to Vivian Hallam are EMI options and the Options granted to Trevor Brown, Susan Hagan and Qu Li are unapproved options. The exercise price of the Options is 7.75p, being the closing mid-market price of an Ordinary Share on 24 March 2023, the date of grant. The Options will vest from 27 March 2024 and be exercisable up to 27 March 2033, subject to continued employment. The Options granted to Trevor Brown and Vivian Hallam, as Executive Directors of the Company, have an additional performance related vesting criteria that the closing mid-market price of an Ordinary Share must exceed 9.6875p (being a 25% premium to the Option exercise price) for 10 business days out of a consecutive 30 business day period.

 

Following the grant of the Options and surrender of historic options held by Viv Hallam, the Company now has options outstanding over a total of 7,022,192 Ordinary Shares, equivalent to 11.0% of the Company's current issued share capital.

 

Further details of the Options can be found in the Notification of Dealing Form below.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Trevor Brown

Chief Executive Officer

Vivian Hallam

Executive Director

Susan Hagan

Non-Executive Director

Qu Li

Non-Executive Director

 

 

2

 

Reason for the notification

 

a)

 

Position/status

 

See 1a) above 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Braveheart Investment Group plc

b)

 

LEI

 

2138006HQ3COMU626I61

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 2 pence each in Braveheart Investment Group plc

 

GB00B13XV322

b)

 

Nature of the transactions

 

Grant of options over ordinary shares

c)

 

Price(s) and volume(s)

 

 

Price: Exercise price of 7.75p per option

 

Trevor Brown

1,250,000

Vivian Hallam

1,250,000

Susan Hagan

200,000

Qu Li

200,000

d)

 

Aggregated information

- Aggregated volume

- Price

- Principal amount

 

N/A

 

e)

 

Dates of the transaction

 

24 March 2023

f)

Place of transaction

Outside a trading venue

 

For further information:

 

Braveheart Investment Group plc

Tel: 01738 587555

Trevor Brown CEO

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: 020 3328 5656

David Worlidge / James Reeve / George Payne

Peterhouse Capital Limited (Joint Broker)

Tel: 020 7469 0936

Duncan Vasey / Lucy Williams

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDGGDXXUDDGXL
Date   Source Headline
16th Jul 20187:00 amRNSUpdate on fund management business
12th Jul 20187:00 amRNSProposed funding round by Paraytec Limited
10th Jul 201810:44 amRNSHolding(s) in Company
25th Jun 20187:00 amRNSFurther re. Notice of Annual General Meeting
21st Jun 20185:16 pmRNSConfirmation of Posting
20th Jun 201810:30 amRNSAppointment of Joint Broker
18th Jun 20187:02 amRNSNotice of General Meeting
18th Jun 20187:00 amRNSFinal Results
26th Apr 20187:00 amRNSTrading Update
9th Apr 20185:11 pmRNSThird party investment into Gyrometric Systems Ltd
16th Jan 20184:24 pmRNSChange of Registered Office
19th Oct 20177:00 amRNSHalf-year Report
13th Sep 20177:00 amRNSUpdate re. Portfolio investment
1st Sep 20177:00 amRNSRetirement of Director and Total Voting Rights
8th Aug 20177:00 amRNSIssue of Equity
20th Jul 201711:19 amRNSResult of AGM
20th Jul 20177:00 amRNSAGM Statement
21st Jun 20177:00 amRNSFinal Results for the year ended 31 March 2017
7th Jun 20174:08 pmRNSDirectorate Change
20th Apr 20177:00 amRNSTrading Update
9th Jan 20177:00 amRNSStrategic Investment and Trading Update
12th Oct 20167:00 amRNSHalf-year Report
16th Sep 201611:18 amRNSDisposal of interest in Investee Company
2nd Aug 201612:08 pmRNSConditional disposal of interest-Investee Company
29th Jul 201611:13 amRNSStmnt re Share Price Movement
26th Jul 20169:32 amRNSHolding(s) in Company
19th Jul 201611:46 amRNSResult of AGM
19th Jul 20167:00 amRNSAGM Statement
13th Jul 20163:26 pmRNSDirectors' Dealings
8th Jul 20163:07 pmRNSInvestment in Kirkstall Limited
4th Jul 20167:00 amRNSInvestment in Paraytec Limited
23rd Jun 20168:45 amRNSAnnual Results
3rd Mar 20167:00 amRNSChange of Nomad & Broker and Directorate Changes
15th Jan 20169:36 amRNSDirectors' Dealings
8th Jan 201612:36 pmRNSDisposal of interest in WhiteRock Capital Partners
15th Dec 20152:33 pmRNSCompletion of sale of interest in Biopta
27th Nov 20157:00 amRNSDisposal of interest in Investee Company
2nd Nov 20152:35 pmRNSHalf Yearly Report & Disposal
24th Sep 201512:15 pmRNSResult of AGM and Directorate Change
3rd Sep 20157:00 amRNSDirector/PDMR Shareholding
2nd Sep 201512:30 pmRNSPosting of Results and Notice of AGM
24th Aug 20157:00 amRNSPreliminary Results and Board Changes
26th Jun 20152:20 pmRNSChange of address and registered office
6th May 20157:01 amRNSCompletion of restructuring and Directorate change
30th Apr 201511:21 amRNSBraveheart enters into partnership with Seedrs
30th Apr 20157:00 amRNSTermination of partnership
20th Apr 20157:00 amRNSDirectorate Change
23rd Dec 20147:00 amRNSRealisation of Investment
15th Dec 20147:00 amRNSHalf Yearly Report
4th Dec 20147:00 amRNSLondon Co-investment Fund partnership

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.